Home » Topics » Disease categories and therapies » Musculoskeletal

Musculoskeletal
RSS

Antiinflammatory imidazolyl compounds from Searle

May 20, 1997

AutoImmune reports preliminary results from phase II trials of Colloral

May 14, 1997

Tularik receives U.S. patent relating to enzyme associated with inflammation

May 14, 1997

Panax to acquire CorBec

May 13, 1997

BioSpecifics receives grant to develop collagenase injection for Dupuytren's disease

May 12, 1997

BioCryst receives milestone payment from Torii

May 7, 1997

British Biotech and SynPhar sign research collaboration

May 7, 1997

Biosource Technologies awarded NIH grant to develop melanin as an antiinflammatory compound

May 6, 1997

Biomatrix's viscosupplementation product to be distributed by Bayer

May 2, 1997

Clodronate shows comparable efficacy to indomethacin in a rat model of arthritis

May 2, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 31, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 31, 2025.
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...
IMV-101 shows promise for B-cell malignancies
BioWorld Science
IMV-101 is a new CAR T-cell therapy targeting CD19 developed by Suzhou Immunofoco Biotechnology Co. Ltd. for the potential treatment of B-cell malignancies and...